EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Tegileridine versus Sufentanil for Patient-Controlled Intravenous Analgesia After Cesarean Delivery: A Randomized Double-Blind Trial

Jing Hu iD, Lianchun Ou, Fangyun Wei, Yanmin Wei, Xinying Guo, Yong Zhang, Haiping Xu iD, Lingyu Wang

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s638340 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Jing Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Guangzhou Women and Children's Medical Center Liuzhou Hospital, Liuzhou, 545006, People's Republic of China. Hauptthemen laut MEDLINE: Analgesia, Patient-Controlled, Analgesics, Opioid, Cesarean Section, Postoperative Pain. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesia, Patient-ControlledAnalgesics, OpioidCesarean SectionPostoperative PainSufentanilSpiro CompoundsNaphthalenesAdultFemaleHumansPregnancyDouble-Blind MethodPostoperative Nausea and Vomiting

Stichwörter der Autor:innen

cesarean deliverypatient-controlled intravenous analgesiapostoperative nausea and vomitingquality of recoverysufentaniltegileridine

Substanzen

Analgesics, OpioidSufentaniltegileridineSpiro CompoundsNaphthalenes

Autor:innen und Institutionen

  • Department of Anesthesiology, Guangzhou Women and Children's Medical Center Liuzhou Hospital, Liuzhou, 545006, People's Republic of China.
  • Department of Anesthesiology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, People's Republic of China.

ORCID-Profile: Jing Hu, Haiping Xu

Zitieren

APA

Hu, J., Ou, L., Wei, F., Wei, Y., Guo, X., Zhang, Y., Xu, H., & Wang, L. (2026). Tegileridine versus Sufentanil for Patient-Controlled Intravenous Analgesia After Cesarean Delivery: A Randomized Double-Blind Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s638340

Vancouver

Hu J, Ou L, Wei F, Wei Y, Guo X, Zhang Y, et al. Tegileridine versus Sufentanil for Patient-Controlled Intravenous Analgesia After Cesarean Delivery: A Randomized Double-Blind Trial. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s638340

BibTeX
@article{Hu2026,
  author = {Hu, Jing and Ou, Lianchun and Wei, Fangyun and Wei, Yanmin and Guo, Xinying and Zhang, Yong and Xu, Haiping and Wang, Lingyu},
  title = {Tegileridine versus Sufentanil for Patient-Controlled Intravenous Analgesia After Cesarean Delivery: A Randomized Double-Blind Trial},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s638340}
}
Kostenlos starten →